Challenges in identifying cancer genes by analysis of exome sequencing data
Open Access
- 15 July 2016
- journal article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 7 (1), 12096
- https://doi.org/10.1038/ncomms12096
Abstract
Massively parallel sequencing has permitted an unprecedented examination of the cancer exome, leading to predictions that all genes important to cancer will soon be identified by genetic analysis of tumours. To examine this potential, here we evaluate the ability of state-of-the-art sequence analysis methods to specifically recover known cancer genes. While some cancer genes are identified by analysis of recurrence, spatial clustering or predicted impact of somatic mutations, many remain undetected due to lack of power to discriminate driver mutations from the background mutational load (13–60% recall of cancer genes impacted by somatic single-nucleotide variants, depending on the method). Cancer genes not detected by mutation recurrence also tend to be missed by all types of exome analysis. Nonetheless, these genes are implicated by other experiments such as functional genetic screens and expression profiling. These challenges are only partially addressed by increasing sample size and will likely hold even as greater numbers of tumours are analysed.Keywords
This publication has 52 references indexed in Scilit:
- Comprehensive identification of mutational cancer driver genes across 12 tumor typesScientific Reports, 2013
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer driversMolecular Systems Biology, 2013
- A Landscape of Driver Mutations in MelanomaCell, 2012
- Molecular signatures database (MSigDB) 3.0Bioinformatics, 2011
- International network of cancer genome projectsNature, 2010
- A comprehensive catalogue of somatic mutations from a human cancer genomeNature, 2009
- The cancer genomeNature, 2009
- DNA sequencing of a cytogenetically normal acute myeloid leukaemia genomeNature, 2008
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008